EQT Funds and Luxinva S.A. to acquire Dechra Pharmaceuticals for £4.459 billion
LONDON, UK: Freya Bidco Limited has agreed to acquire entire issued, and to be issued, ordinary share capital of Dechra Pharmaceuticals at the rate of 3,875 pence in cash for each Dechra share. Freya Bidco Limited is a newly formed…